VSM MedTech Ltd.

VSM-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about VSM-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
April 21, 2014

Likes this. Core business is selling broadcast equipment to cable and telcos. Have done a great job of creating shareholder value by selling off non-core assets such as wireless spectrum and real estate in Saskatchewan. Thinks they are kind of getting to the end of the line and he has sold his position.

Likes this. Core business is selling broadcast equipment to cable and telcos. Have done a great job of creating shareholder value by selling off non-core assets such as wireless spectrum and real estate in Saskatchewan. Thinks they are kind of getting to the end of the line and he has sold his position.

James Hodgins
Chief Investment Officer, Curvature Hedge Strategies
Price
$0.050
Owned
No
DON'T BUY
DON'T BUY
August 18, 2006
Recently entered into a financing agreement. Cash strapped. Existing shareholders tend to get totally diluted of their positions.
VSM MedTech Ltd. (VSM-T)
August 18, 2006
Recently entered into a financing agreement. Cash strapped. Existing shareholders tend to get totally diluted of their positions.
Robert Floyd
President, R A Floyd Management
Price
$0.090
Owned
No
SELL
SELL
July 25, 2006
Ranks near the bottom. Earnings have been shaved by 23%. Recent financing was very dilutive.
Ranks near the bottom. Earnings have been shaved by 23%. Recent financing was very dilutive.
Robert McWhirter
President, Selective Asset Management
Price
$0.070
Owned
No
DON'T BUY
DON'T BUY
May 4, 2006
Ranks in the bottom 1% of his database. Earnings estimates have been revised downwards 12% in the last 90 days.
Ranks in the bottom 1% of his database. Earnings estimates have been revised downwards 12% in the last 90 days.
Robert McWhirter
President, Selective Asset Management
Price
$0.475
Owned
No
DON'T BUY
DON'T BUY
March 13, 2006
It is interesting technology. The company is suffering. Give it a pass. He has owned in the past.
It is interesting technology. The company is suffering. Give it a pass. He has owned in the past.
Robert McWhirter
President, Selective Asset Management
Price
$0.530
Owned
No
DON'T BUY
DON'T BUY
December 8, 2005
Has very good technology, but unfortunately it is still in the early stages of being rolled out to the medical community. In the bottom 15% of his database. Earnings estimates have been shaved by about 5% in the last 90 days and 20% in the last 60 days. Most recent quarter had a negative earnings surprise. Expected to lose $0.23 in ’06 and $0.15 in ’07.
VSM MedTech Ltd. (VSM-T)
December 8, 2005
Has very good technology, but unfortunately it is still in the early stages of being rolled out to the medical community. In the bottom 15% of his database. Earnings estimates have been shaved by about 5% in the last 90 days and 20% in the last 60 days. Most recent quarter had a negative earnings surprise. Expected to lose $0.23 in ’06 and $0.15 in ’07.
Robert McWhirter
President, Selective Asset Management
Price
$0.700
Owned
No
PAST TOP PICK
PAST TOP PICK
May 31, 2005
(A Top Pick Nov 19/03. Down 83%.) Stock did very well for a whle, but the company was not able to make a viable business. Sold off a long time ago.
(A Top Pick Nov 19/03. Down 83%.) Stock did very well for a whle, but the company was not able to make a viable business. Sold off a long time ago.
Brendan Kyne
Chairman and Chief Executive Officer, Leeward Hedge Funds Inc
Price
$0.560
Owned
No
DON'T BUY
DON'T BUY
April 7, 2005
A tough one because the company is struggling with a management team that is being paid too much. Not doing well from a sales point of view and one of their competitors is starting to give away products as a bundling package.
A tough one because the company is struggling with a management team that is being paid too much. Not doing well from a sales point of view and one of their competitors is starting to give away products as a bundling package.
Peter Hodson
CEO & Head of Research, 5i Research Inc.
Price
$0.600
Owned
No
VAGUE
VAGUE
February 2, 2005
The bane of his existence. Comes back to haunt him. Has not got this one right at all.
VSM MedTech Ltd. (VSM-T)
February 2, 2005
The bane of his existence. Comes back to haunt him. Has not got this one right at all.
David Taylor, MBA, CFA
Vice President & Portfolio Manager, Goodman & Company, Investment Counsel
Price
$0.900
Owned
Yes
VAGUE
VAGUE
January 14, 2005
Have had a lot of trouble. Lost their CEO. Have to do more research with management before investing. Have some interesting technology. Starting to look interesting.
VSM MedTech Ltd. (VSM-T)
January 14, 2005
Have had a lot of trouble. Lost their CEO. Have to do more research with management before investing. Have some interesting technology. Starting to look interesting.
Scott Morrison
Senior Portfolio Manager, Empire Financial Group
Price
$1.040
Owned
No
BUY
BUY
December 20, 2004
Likes the company and their technology. Management team is improving operations, but they get paid way too much money. The question is; are they going to increase their sales base and ultimately sell the company or dwindle as a small cap. Under $1 there's not a whole lot of risk.
VSM MedTech Ltd. (VSM-T)
December 20, 2004
Likes the company and their technology. Management team is improving operations, but they get paid way too much money. The question is; are they going to increase their sales base and ultimately sell the company or dwindle as a small cap. Under $1 there's not a whole lot of risk.
Peter Hodson
CEO & Head of Research, 5i Research Inc.
Price
$0.940
Owned
No
DON'T BUY
DON'T BUY
December 9, 2004
Not expected to earn any money. In the bottom 2% of the database. Year over year sales are down 43% and earnings down 71%.
VSM MedTech Ltd. (VSM-T)
December 9, 2004
Not expected to earn any money. In the bottom 2% of the database. Year over year sales are down 43% and earnings down 71%.
Robert McWhirter
President, Selective Asset Management
Price
$0.670
Owned
No
DON'T BUY
DON'T BUY
November 12, 2004
CFO is gone and they have laid off the COO. Have sold zero units of their new technology. Running out of cash.
VSM MedTech Ltd. (VSM-T)
November 12, 2004
CFO is gone and they have laid off the COO. Have sold zero units of their new technology. Running out of cash.
Duncan Stewart
Director of Research & Analysis, DSAM Consulting
Price
$0.690
Owned
No
BUY WEAKNESS
BUY WEAKNESS
November 4, 2004
Have been looking at it. Been beaten up more than it should be. Entering tax-loss selling season, so it could drop further. Still believes in the technology. New management could make a difference.
VSM MedTech Ltd. (VSM-T)
November 4, 2004
Have been looking at it. Been beaten up more than it should be. Entering tax-loss selling season, so it could drop further. Still believes in the technology. New management could make a difference.
Peter Hodson
CEO & Head of Research, 5i Research Inc.
Price
$0.900
Owned
No
WAIT
WAIT
September 24, 2004
Short term, it won't be good. Expect some tax loss selling in the last quarter. May take 3/4 years to get a big bang. Good product.
VSM MedTech Ltd. (VSM-T)
September 24, 2004
Short term, it won't be good. Expect some tax loss selling in the last quarter. May take 3/4 years to get a big bang. Good product.
Peter Hodson
CEO & Head of Research, 5i Research Inc.
Price
$1.460
Owned
No
Showing 1 to 15 of 58 entries